Barinthus Biotherapeutics plc. 5 SEC Filings

Filed On	Filing
10 Feb 2023	Form 5: Wright Robin, Director Granted 18,604 Share Option (Right to Buy)
10 Feb 2023	Form 5: Scheeren Joseph, Director Granted 18,604 Share Option (Right to Buy)
10 Feb 2023	Form 5: Phillips Anne M., Director Granted 18,604 Share Option (Right to Buy)
10 Feb 2023	Form 5: Morgon Pierre A., Director Granted 18,604 Share Option (Right to Buy)
10 Feb 2023	Form 5: Hammacher Alex, Director Granted 18,604 Share Option (Right to Buy)
10 Feb 2023	Form 5: Dawes Karen A, Director Granted 18,604 Share Option (Right to Buy)
11 Feb 2022	Form 5: Griffiths Graham, Chief Business Officer Received 115,799 shares by exercise or conversion ($46.3)

Comments